<DOC>
	<DOCNO>NCT02893410</DOCNO>
	<brief_summary>Patients treat oral sub-cutaneous drug polycythemia vera essential thrombocythemia complete unique paper questionnaire order describe observance , side effect appreciation take drug .</brief_summary>
	<brief_title>Drug Observance Side Effects Cytoreductive Drugs PV ET Patients</brief_title>
	<detailed_description>During one year , patient PV ET follow centre , take drug treat MPN , identify . The investigator submit mail directly consultation unique questionnaire contain 25 question concern patient characteristic , evaluation observance , identification side effect appreciation drug . After completion questionnaire , patient identify follow collect new data thrombotic event phenotypic evolution .</detailed_description>
	<mesh_term>Polycythemia</mesh_term>
	<mesh_term>Polycythemia Vera</mesh_term>
	<mesh_term>Thrombocytosis</mesh_term>
	<mesh_term>Thrombocythemia , Essential</mesh_term>
	<criteria>Patients PV ET SMF Patients take oral subcutaneous drug treat MPN . Patients agree complete questionnaire Patients low risk PV ET take treatment Patients unable complete questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>